非编码RNA作为Hippo通路在心脏发育和心血管疾病中的调节者
Mengyang Song1, He Wang1, Caixia Liu2
1Department of Cardiology, The Second Hospital of Jilin University, Changchun, China.
Frontiers in pharmacology
|May 3, 2024
概括
非编码RNAs (ncRNAs) 与Hippo通路相互作用,调节心血管健康. 这种相互作用为治疗和预防心血管疾病提供了潜在的新治疗点.
科学领域:
- 分子生物学分子生物学
- 心血管科学 心血管科学
- 遗传学 遗传学 是一个
背景情况:
- 心血管疾病 (CVD) 是由复杂的基因环境相互作用引起的,影响多个信号通路.
- 河马通路是细胞增殖,细胞亡和分化的保护调节器,涉及心血管疾病,癌症和再生.
- 非编码RNAs (ncRNAs) 是关键的基因表达调节器,具有多种功能,在疾病机制中越来越多地被认可.
研究的目的:
- 审查关于心血管疾病的河马通路中ncRNAs的调节作用.
- 探索针对心血管疾病治疗和预防的ncRNA-Hippo通路相互作用的治疗潜力.
主要方法:
- 关于ncRNAs,Hippo通路和心血管疾病的最新研究的文献综述.
- 分析基底的分子机制的ncRNA调节的河马路的组件.
- 在这些相互作用中识别潜在的治疗点.
主要成果:
- ncRNAs调节Hippo通路的活动,影响心肌纤维化,心肌细胞增殖,细胞亡和过度缩小.
- 特定的ncRNA和Hippo通路组件被确定为心血管疾病发病过程中的关键参与者.
- ncRNAs与Hippo路径之间的相互作用为治疗干预提供了新的途径.
结论:
- 在心血管疾病的发展中,ncRNA-Hippo通路相互作用至关重要.
- 针对这些相互作用,有望为心血管疾病开发新的治疗策略.
- 对这些分子机制的进一步研究可以揭示心血管疾病的创新治疗方法和预防措施.
相关概念视频
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
01:23Regulation of Expression at Multiple Steps
899
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
899
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
02:33Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
02:23Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K